ABO hemolytic disease of the fetus and newborn: an iatrogenic complication of heterologous assisted reproductive technology-induced pregnancy.

Antonio Alberto Zuppa, Valentina Cardiello, Marco Lai, Luigi Cataldi, Vito D'Andrea, Costantino Romagnoli

Research output: Contribution to journalArticle

Abstract

BACKGROUND: ABO hemolytic disease of the fetus and newborn (ABO HDFN) may manifest itself in cases of mothers belonging to blood group O and newborns of groups A or B and more frequently in group A and less so in group B. CASE STUDY: The case subjects are twin-birth newborns with ABO HDFN, of group AB born to a mother of group O. These cases of ABO HDFN prove inconsistent with Mendel's law of segregation. RESULTS AND CONCLUSION: This case study finds its explanation in new methods of assisted reproduction, particularly heterologous in vitro fertilization with ovodonation.
Original languageEnglish
Pages (from-to)2102-2104
Number of pages3
JournalTransfusion
Publication statusPublished - 2010

Keywords

  • ABO hemolytic

Fingerprint

Dive into the research topics of 'ABO hemolytic disease of the fetus and newborn: an iatrogenic complication of heterologous assisted reproductive technology-induced pregnancy.'. Together they form a unique fingerprint.

Cite this